Daskalaki, W., Wardelmann, E., Port, M., Stock, K., Steinestel, J., Huss, S., . . . Eder, S. (2018). Expression levels of hnRNP K and p21(WAF1/CIP1 )are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma. Int J Mol Med.
Citación estilo ChicagoDaskalaki, Wassiliki, Eva Wardelmann, Matthias Port, Katharina Stock, Julie Steinestel, Sebastian Huss, Jan Sperveslage, Konrad Steinestel, y Stefan Eder. "Expression Levels of HnRNP K and P21(WAF1/CIP1 )are Associated With Resistance to Radiochemotherapy Independent of P53 Pathway Activation in Rectal Adenocarcinoma." Int J Mol Med 2018.
Cita MLADaskalaki, Wassiliki, et al. "Expression Levels of HnRNP K and P21(WAF1/CIP1 )are Associated With Resistance to Radiochemotherapy Independent of P53 Pathway Activation in Rectal Adenocarcinoma." Int J Mol Med 2018.